What does the National Action Plan ask for?
The UK's 5-year AMR National Action Plan 2024 to 2029, published in May 2024, sets the national strategy to slow antimicrobial resistance. Two of its targets are concrete for providers: prevent any increase in gram-negative bloodstream infections against a 2019 to 2020 baseline, and cut total human antibiotic use by 5 percent.
Both point in the same direction. The most reliable way to use fewer antibiotics, and to hold resistant bloodstream infections down, is to stop the infections happening in the first place.
Why is this such a serious threat?
Antimicrobial resistance is already linked to more than 1.2 million deaths a year worldwide, and on current trends that figure is projected to reach around 10 million a year by 2050. As resistance spreads, infections that were once routine to treat become dangerous again.
For a healthcare provider, that turns infection prevention from a quality metric into a strategic priority, and a regulated one.
Where do water and air safety come in?
Resistant organisms do not only pass person to person. Many shelter in biofilm, the protective layer inside water systems, where they are roughly a thousand times more resistant to conventional disinfection, and others travel in the air of clinical spaces. Both are routes that infection-prevention effort can close.
That is why water safety and air quality are not separate from the AMR agenda, they are part of it: every infection prevented is an antibiotic course avoided and a chance for resistance to spread removed.
How do you reduce the infection load?
On the water side, the target is the biofilm itself. Approaches that go after biofilm directly are independently shown to remove 99.99 percent of it using a recognised standard method (ASTM E2799), which is precisely the reservoir conventional dosing leaves behind. At one major UK site, a recurring waterborne pathogen problem was brought to 0 cfu/g in four days, confirmed by a UKAS-accredited laboratory.
On the air side, removing airborne pathogens from clinical spaces, without introducing ozone or other harmful by-products, reduces the airborne route. Together, demonstrably clean water and air lower the infection load that drives antibiotic use and resistance.